Citadel Advisors’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $401K | Sell |
237,000
-98,800
| -29% | -$203K | ﹤0.01% | 9812 |
|
|
2025
Q4 | $665K | Sell |
335,800
-44,200
| -12% | -$142K | ﹤0.01% | 8323 |
|
|
2025
Q3 | $1.11M | Buy |
380,000
+163,800
| +76% | +$377K | ﹤0.01% | 7322 |
|
|
2025
Q2 | $391K | Sell |
216,200
-149,100
| -41% | -$265K | ﹤0.01% | 9194 |
|
|
2025
Q1 | $548K | Sell |
365,300
-6,800
| -2% | -$17.2K | ﹤0.01% | 8279 |
|
|
2024
Q4 | $878K | Sell |
372,100
-155,100
| -29% | -$2.72M | ﹤0.01% | 7318 |
|
|
2024
Q3 | $15.5M | Buy |
527,200
+460,600
| +692% | +$10.6M | ﹤0.01% | 2335 |
|
|
2024
Q2 | $823K | Buy |
66,600
+5,600
| +9% | +$118K | ﹤0.01% | 6998 |
|
|
2024
Q1 | $1.24M | Sell |
61,000
-294,200
| -83% | -$6.78M | ﹤0.01% | 6495 |
|
|
2023
Q4 | $8M | Sell |
355,200
-109,600
| -24% | -$2.32M | ﹤0.01% | 3139 |
|
|
2023
Q3 | $7.73M | Buy |
464,800
+90,200
| +24% | +$1.79M | ﹤0.01% | 3015 |
|
|
2023
Q2 | $9.19M | Sell |
374,600
-60,900
| -14% | -$1.47M | ﹤0.01% | 2790 |
|
|
2023
Q1 | $10.5M | Sell |
435,500
-285,200
| -40% | -$7.9M | ﹤0.01% | 2757 |
|
|
2022
Q4 | $21.3M | Sell |
720,700
-412,700
| -36% | -$14.8M | 0.01% | 1903 |
|
|
2022
Q3 | $47.4M | Buy |
1,133,400
+222,400
| +24% | +$6.01M | 0.01% | 1109 |
|
|
2022
Q2 | $25.6M | Buy |
911,000
+263,200
| +41% | +$6.65M | 0.01% | 1601 |
|
|
2022
Q1 | $24.1M | Sell |
647,800
-415,000
| -39% | -$17.6M | 0.01% | 1776 |
|
|
2021
Q4 | $46.4M | Sell |
1,062,800
-67,700
| -6% | -$3.55M | 0.01% | 1228 |
|
|
2021
Q3 | $70.2M | Buy |
1,130,500
+896,600
| +383% | +$74.8M | 0.01% | 881 |
|
|
2021
Q2 | $20M | Sell |
233,900
-40,300
| -15% | -$2.16M | ﹤0.01% | 2088 |
|
|
2021
Q1 | $12.3M | Buy |
274,200
+137,800
| +101% | +$5.42M | ﹤0.01% | 2674 |
|
|
2020
Q4 | $930K | Sell |
136,400
-83,800
| -38% | -$748K | ﹤0.01% | 6950 |
|
|
2020
Q3 | $2.54M | Buy |
220,200
+159,000
| +260% | +$717K | ﹤0.01% | 4282 |
|
|
2020
Q2 | $188K | Buy |
61,200
+22,800
| +59% | +$103K | ﹤0.01% | 8576 |
|
|
2020
Q1 | $158K | Buy |
+38,400
| New | +$254K | ﹤0.01% | 8245 |
|
|
2015
Q4 | – | Sell |
-1,157
| Closed | -$15K | – | 9125 |
|
|
2015
Q3 | $15K | Buy |
1,157
+1,000
| +637% | +$12.6K | ﹤0.01% | 8331 |
|
|
2015
Q2 | $2K | Buy |
+157
| New | +$2.15K | ﹤0.01% | 8624 |
|
|
2015
Q1 | – | Sell |
-57
| Closed | -$1K | – | 8806 |
|
|
2014
Q4 | $1K | Buy |
+57
| New | +$987 | ﹤0.01% | 8418 |
|
|
2014
Q3 | – | Sell |
-671
| Closed | -$27K | – | 8359 |
|
|
2014
Q2 | $27K | Buy |
671
+242
| +56% | +$8.96K | ﹤0.01% | 7141 |
|
|
2014
Q1 | $17K | Sell |
429
-85
| -17% | -$3K | ﹤0.01% | 7358 |
|
|
2013
Q4 | $17K | Buy |
514
+185
| +56% | +$4.91K | ﹤0.01% | 6553 |
|
|
2013
Q3 | $6K | Sell |
329
-371
| -53% | -$6.49K | ﹤0.01% | 6563 |
|
|
2013
Q2 | $11K | Buy |
+700
| New | +$14.8K | ﹤0.01% | 6217 |
|
Other funds holding FLNA
VCM
GC
Citadel Advisors's FLNA Position: Q4 2025 in Review
Citadel Advisors sold out of Filana Therapeutics (FLNA) in Q4 2025, closing a stake of 13,864 shares — an estimated $44.4K sold.
Citadel Advisors first reported a position in FLNA in Q2 2013 and held it in 26 quarters. The position peaked at $26.6M in Q2 2021. 107 funds tracked by Wall St. Rank hold FLNA as of Q4 2025.
- Citadel Advisors reported no remaining Filana Therapeutics position as of Q4 2025 after selling out during the quarter.
- Citadel Advisors sold 13,864 Filana Therapeutics shares in Q4 2025, an estimated $44.4K.
- Citadel Advisors first reported a position in Filana Therapeutics in Q2 2013 and held it in 26 quarters.
- Citadel Advisors's Filana Therapeutics position peaked at $26.6M in Q2 2021.
- 107 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2025.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.